ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Amid pricing spat with U.K. government, Vertex declines to submit data on new CF drug to NICE
August 13, 2018The battle between Vertex Pharmaceuticals and U.K. health officials over cystic fibrosis drug pricing has reached an impasse after NHS England’s “final” offer in July. Now, Vertex is withholding data on new drug Symkevi that patients are anxiously awaitin
Pharma Sources Insight January 2025
